254 results on '"Genetic complexity"'
Search Results
2. Zebrafish: unraveling genetic complexity through duplicated genes
- Author
-
Tasnim, Maliha, Wahlquist, Preston, and Hill, Jonathon T.
- Published
- 2024
- Full Text
- View/download PDF
3. Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases.
- Author
-
Nigro, Ersilia, Amicone, Maria, D'Arco, Daniela, Sellitti, Gina, De Marco, Oriana, Guarino, Maria, Riccio, Eleonora, Pisani, Antonio, and Daniele, Aurora
- Subjects
- *
POLYCYSTIC kidney disease , *MOLECULAR diagnosis , *RECESSIVE genes , *CYSTIC kidney disease , *DOMINANCE (Genetics) - Abstract
Polycystic Kidney Diseases (PKDs) consist of a genetically and phenotypically heterogeneous group of inherited disorders characterized by numerous renal cysts. PKDs include autosomal dominant ADPKD, autosomal recessive ARPKD and atypical forms. Here, we analyzed 255 Italian patients using an NGS panel of 63 genes, plus Sanger sequencing of exon 1 of the PKD1 gene and MPLA (PKD1, PKD2 and PKHD1) analysis. Overall, 167 patients bore pathogenic/likely pathogenic variants in dominant genes, and 5 patients in recessive genes. Four patients were carriers of one pathogenic/likely pathogenic recessive variant. A total of 24 patients had a VUS variant in dominant genes, 8 patients in recessive genes and 15 patients were carriers of one VUS variant in recessive genes. Finally, in 32 patients we could not reveal any variant. Regarding the global diagnostic status, 69% of total patients bore pathogenic/likely pathogenic variants, 18.4% VUS variants and in 12.6% of patients we could not find any. PKD1 and PKD2 resulted to be the most mutated genes; additional genes were UMOD and GANAB. Among recessive genes, PKHD1 was the most mutated gene. An analysis of eGFR values showed that patients with truncating variants had a more severe phenotype. In conclusion, our study confirmed the high degree of genetic complexity at the basis of PKDs and highlighted the crucial role of molecular characterization in patients with suspicious clinical diagnosis. An accurate and early molecular diagnosis is essential to adopt the appropriate therapeutic protocol and represents a predictive factor for family members. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Back to the future: implications of genetic complexity for the structure of hybrid breeding programs.
- Author
-
Technow, Frank, Podlich, Dean, and Cooper, Mark
- Subjects
- *
GENETIC variation , *QUANTITATIVE genetics , *BIOCOMPLEXITY , *GENETIC models , *UNITED States history , *CORN - Abstract
Commercial hybrid breeding operations can be described as decentralized networks of smaller, more or less isolated breeding programs. There is further a tendency for the disproportionate use of successful inbred lines for generating the next generation of recombinants, which has led to a series of significant bottlenecks, particularly in the history of the North American and European maize germplasm. Both the decentralization and the disproportionate contribution of inbred lines reduce effective population size and constrain the accessible genetic space. Under these conditions, long-term response to selection is not expected to be optimal under the classical infinitesimal model of quantitative genetics. In this study, we therefore aim to propose a rationale for the success of large breeding operations in the context of genetic complexity arising from the structure and properties of interactive genetic networks. For this, we use simulations based on the NK model of genetic architecture. We indeed found that constraining genetic space through program decentralization and disproportionate contribution of parental inbred lines, is required to expose additive genetic variation and thus facilitate heritable genetic gains under high levels of genetic complexity. These results introduce new insights into why the historically grown structure of hybrid breeding programs was successful in improving the yield potential of hybrid crops over the last century. We also hope that a renewed appreciation for "why things worked" in the past can guide the adoption of novel technologies and the design of future breeding strategies for navigating biological complexity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases
- Author
-
Daniele, Ersilia Nigro, Maria Amicone, Daniela D’Arco, Gina Sellitti, Oriana De Marco, Maria Guarino, Eleonora Riccio, Antonio Pisani, and Aurora
- Subjects
polycystic kidney diseases ,next-generation sequencing ,ADPKD ,ARPKD ,genetic complexity - Abstract
Polycystic Kidney Diseases (PKDs) consist of a genetically and phenotypically heterogeneous group of inherited disorders characterized by numerous renal cysts. PKDs include autosomal dominant ADPKD, autosomal recessive ARPKD and atypical forms. Here, we analyzed 255 Italian patients using an NGS panel of 63 genes, plus Sanger sequencing of exon 1 of the PKD1 gene and MPLA (PKD1, PKD2 and PKHD1) analysis. Overall, 167 patients bore pathogenic/likely pathogenic variants in dominant genes, and 5 patients in recessive genes. Four patients were carriers of one pathogenic/likely pathogenic recessive variant. A total of 24 patients had a VUS variant in dominant genes, 8 patients in recessive genes and 15 patients were carriers of one VUS variant in recessive genes. Finally, in 32 patients we could not reveal any variant. Regarding the global diagnostic status, 69% of total patients bore pathogenic/likely pathogenic variants, 18.4% VUS variants and in 12.6% of patients we could not find any. PKD1 and PKD2 resulted to be the most mutated genes; additional genes were UMOD and GANAB. Among recessive genes, PKHD1 was the most mutated gene. An analysis of eGFR values showed that patients with truncating variants had a more severe phenotype. In conclusion, our study confirmed the high degree of genetic complexity at the basis of PKDs and highlighted the crucial role of molecular characterization in patients with suspicious clinical diagnosis. An accurate and early molecular diagnosis is essential to adopt the appropriate therapeutic protocol and represents a predictive factor for family members.
- Published
- 2023
- Full Text
- View/download PDF
6. Analysis of genes encoding epigenetic regulators in myeloproliferative neoplasms: Coexistence of a novel SETBP1 mutation in a patient with a p.V617F JAK2 positive myelofibrosis.
- Author
-
Eder-Azanza, Laura, Hurtado, Cristina, Navarro-Herrera, David, Calavia, Diego, Novo, Francisco Javier, and Vizmanos, José Luis
- Subjects
- *
MYELOFIBROSIS , *PROTEIN binding , *GENES , *PROTEIN domains , *CANCER , *HEMATOLOGIC malignancies - Abstract
In recent years it has been shown that the causes of chronic myeloproliferative neoplasms (MPNs) are more complex than a simple signaling aberration and many other mutated genes affecting different cell processes have been described. For instance, mutations in genes encoding epigenetic regulators are more frequent than expected. One of the latest genes described as mutated is SET binding protein 1 (SETBP1). In silico tools have revealed that there are several human SETBP1 paralogous to nuclear receptor binding SET domain protein 1 (NSD1), NSD2 and NSD3, for example, which are also involved in the development of other hematological malignancies. Therefore, the present study analyzed the mutational status of NSD1, NSD2, NSD3 and SETBP1 in BCR-ABL1 negative MPNs with or without Janus kinase 2 (JAK2) p.V617F mutation. The present study revealed that the NSD genes are not frequently mutated in MPNs. However, a novel SETBP1 mutation was identified in a patient with p.V617F JAK2 positive primary myelofibrosis. These results provide further insight into the genetic complexity of MPNs. [ABSTRACT FROM AUTHOR]
- Published
- 2019
7. NEW THEORY OF EVOLUTION FROM GENETIC COMPLEXITY OF DIVERSE PERSPECTIVES
- Author
-
Y. V. Subba Rao
- Subjects
Genetic complexity ,History ,Data science - Abstract
In this study, a new hypothesis of evolution is proposed. Genetic complexity provides a plausible hypothesis of the evolution of life on Earth and is supported by ample evidence from different perspectives. The current theory of evolution and natural selection proposed by Darwin is accepted in biology, plausibly, for want of a more viable alternative in based on the recent advances made in cell biology, molecular biology, and genetics. The proposed hypothesis of evolution based on the different perspectives of genetic complexity addresses the two critical areas of advanced complex life of Cambrian explosion and the development of even more complex and intricate human brain in contradistinction to the Evolution Theory envisaged by Charles Darwin.
- Published
- 2021
8. Genetic basis and adaptation trajectory of soybean from its temperate origin to tropics
- Author
-
Chao Fang, Baohui Liu, Haiyang Li, James L. Weller, Liyu Chen, Zhuoran Gan, Yongli Li, Kun Kou, Chunbao Zhang, Lingping Kong, Xiaohui Yuan, Lingshuang Wang, Zhihong Hou, Fanjiang Kong, Kai Wang, Sijia Lu, Tong Su, Lin Yue, Yuhang Zhang, Qun Cheng, and Lidong Dong
- Subjects
Crops, Agricultural ,Agricultural genetics ,Plant domestication ,Photoperiod ,Science ,Quantitative Trait Loci ,General Physics and Astronomy ,Locus (genetics) ,Flowers ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,Evolutionary genetics ,Hypocotyl ,Quantitative Trait, Heritable ,Gene Expression Regulation, Plant ,Temperate climate ,Genetic variation ,Allele ,Plant Proteins ,Genetic complexity ,Genetics ,Tropical Climate ,Multidisciplinary ,Low latitude ,fungi ,Tropics ,Gene Expression Regulation, Developmental ,food and beverages ,General Chemistry ,Sequence Analysis, DNA ,biochemical phenomena, metabolism, and nutrition ,Adaptation, Physiological ,DNA-Binding Proteins ,Soybeans ,Adaptation ,Genome, Plant ,Transcription Factors - Abstract
Soybean (Glycine max) serves as a major source of protein and edible oils worldwide. The genetic and genomic bases of the adaptation of soybean to tropical regions remain largely unclear. Here, we identify the novel locus Time of Flowering 16 (Tof16), which confers delay flowering and improve yield at low latitudes and determines that it harbors the soybean homolog of LATE ELONGATED HYPOCOTYL (LHY). Tof16 and the previously identified J locus genetically additively but independently control yield under short-day conditions. More than 80% accessions in low latitude harbor the mutations of tof16 and j, which suggests that loss of functions of Tof16 and J are the major genetic basis of soybean adaptation into tropics. We suggest that maturity and yield traits can be quantitatively improved by modulating the genetic complexity of various alleles of the LHY homologs, J and E1. Our findings uncover the adaptation trajectory of soybean from its temperate origin to the tropics., How soybean, a temperate origin crop, adapted to a tropical environment remains unclear. Here, the authors report Tof16, an ortholog of LHY, and the previously identified J locus, control soybean yield under short-day condition and loss of function of these two genes contributes to the adaptation to tropics.
- Published
- 2021
9. Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity
- Author
-
Lucy Fu, Barina Aqil, Lawrence J. Jennings, Arash Mohtashamian, Juehua Gao, Amy Chadburn, Qing Chen, Yi Hua Chen, Madina Sukhanova, Olga Frankfurt, and Xinyan Lu
- Subjects
Genetic complexity ,Cancer Research ,endocrine system diseases ,business.industry ,Lymphoblastic Leukemia ,Hematology ,medicine.disease ,Tp53 mutation ,Lymphoma ,Leukemia ,Oncology ,hemic and lymphatic diseases ,medicine ,Cancer research ,Mast cell sarcoma ,business ,Rare disease - Abstract
Mast cell sarcoma is a rare disease associated with a dismal prognosis. We report a unique case of mast cell sarcoma arising in a patient with a history of T-lymphoblastic leukemia/lymphoma (T-ALL)...
- Published
- 2021
10. Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
- Author
-
Nakul Katyal and Raghav Govindarajan
- Subjects
amyotrophic lateral sclerosis ,clinical trials ,animal models ,biomarkers ,genetic complexity ,infrastructural issues ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to develop a successful therapeutic strategy for this disease have failed. Genetic complexity, inadequate animal models, poor clinical trial design, lack of sensitive biomarkers, and diagnostic delays are some of the potential reasons limiting any significant development in ALS clinical trials. In this review, we have outlined the possible reasons for failure of ALS clinical trials, addressed the factors limiting timely diagnosis, and suggested possible solutions for future considerations for each of the shortcomings.
- Published
- 2017
- Full Text
- View/download PDF
11. A multidimensional computational exploration of congenital myasthenic syndrome causing mutations in human choline acetyltransferase
- Author
-
Kam Y. J. Zhang, Matej Janežič, and Kalarickal V. Dileep
- Subjects
0301 basic medicine ,In silico ,Genomic research ,Biology ,GPI-Linked Proteins ,Biochemistry ,Protein Structure, Secondary ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Missense mutation ,Computer Simulation ,Molecular Biology ,health care economics and organizations ,Myasthenic Syndromes, Congenital ,Genetics ,Genetic complexity ,Genetic data ,Cell Biology ,Congenital myasthenic syndrome ,Pathogenicity ,medicine.disease ,Choline acetyltransferase ,030104 developmental biology ,030220 oncology & carcinogenesis ,Mutation ,Acetylcholinesterase - Abstract
Missense mutations of human choline acetyltransferase (CHAT) are mainly associated with congenital myasthenic syndrome (CMS). To date, several pathogenic mutations have been reported, but due to the rarity and genetic complexity of CMS and difficult genotype-phenotype correlations, the CHAT mutations, and their consequences are underexplored. In this study, we systematically sift through the available genetic data in search of previously unreported pathogenic mutations and use a dynamic in silico model to provide structural explanations for the pathogenicity of the reported deleterious and undetermined variants. Through rigorous multiparameter analyses, we conclude that mutations can affect CHAT through a variety of different mechanisms: by disrupting the secondary structure, by perturbing the P-loop through long-range allosteric interactions, by disrupting the domain connecting loop, and by affecting the phosphorylation process. This study provides the first dynamic look at how mutations affect the structure and catalytic activity in CHAT and highlights the need for further genomic research to better understand the pathology of CHAT.
- Published
- 2021
12. Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.
- Author
-
Katyal, Nakul and Govindarajan, Raghav
- Subjects
AMYOTROPHIC lateral sclerosis ,DRUG approval - Abstract
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to develop a successful therapeutic strategy for this disease have failed. Genetic complexity, inadequate animal models, poor clinical trial design, lack of sensitive biomarkers, and diagnostic delays are some of the potential reasons limiting any significant development in ALS clinical trials. In this review, we have outlined the possible reasons for failure of ALS clinical trials, addressed the factors limiting timely diagnosis, and suggested possible solutions for future considerations for each of the shortcomings. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Characterization of a Novel NDM-5-Harboring Plasmid from a Carbapenem-Resistant Escherichia coli Isolate from China
- Author
-
Xinying Du, Zhonghong Li, Kezong Qi, Lanfen Lu, Hongbin Song, Yanfeng Lin, Lang Yang, Peng Li, Dongdong Yin, Hui Ma, and Kaiying Wang
- Subjects
Genetics ,Genetic complexity ,Active monitoring ,Strain (biology) ,Biology ,Carbapenem resistant Escherichia coli ,medicine.disease_cause ,NDM-5 ,Plasmid ,Infection and Drug Resistance ,IncFII ,medicine ,Escherichia coli ,carbapenem resistant ,Gene ,Southern blot ,Original Research ,ST5415 - Abstract
Dongdong Yin,1,2,* Yanfeng Lin,1,3,* Zhonghong Li,1,4,* Hui Ma,5,* Lanfen Lu,6 Kaiying Wang,1,3 Lang Yang,1,3 Xinying Du,1 Peng Li,1 Kezong Qi,2 Hongbin Song1,* 1Center for Disease Control and Prevention of PLA, Beijing, People’s Republic of China; 2Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control College of Animal Science and Technology, Anhui Agricultural University, Hefei, People’s Republic of China; 3Institute for Disease Control and Prevention, AMMS, Beijing, People’s Republic of China; 4College of Environmental and Chemical Engineering, Nanchang Hangkong University, Nanchang, People’s Republic of China; 5The Sixth Medical Center of PLA General Hospital, Beijing, People’s Republic of China; 6Department of Laboratory Diagnosis, Sun Yat-Sen University Affiliated Zhongshan Hospital, Zhongshan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Peng Li; Kezong Qi Email jiekenlee@126.com; qkz@ahau.edu.cnBackground: A carbapenem-resistant Escherichia coli (sequence type 5415) strain was isolated from a male patient through routine surveillance in 2018 in Guangzhou, China.Materials and Methods: Bacteria were isolated from a sputum culture and identified by using the Vitek 2 compact system. The blaNDM-5 gene was amplified and confirmed by sequencing. Antimicrobial susceptibility testing was determined by a Vitek 2 compact system. The blaNDM-5 gene was located by Southern blotting. Whole-genome sequencing was carried out using both Illumina MiSeq and Oxford Nanopore MinION.Results: S1-PFGE and Southern blotting showed that the blaNDM-5 gene was located on a novel 66-kb IncFII [F2:A-:B-] plasmid. Conjugation assays revealed that the blaNDM-5-bearing plasmid was self-transferrable. Genomic sequencing and comparative analysis suggested that plasmid p2947-NDM5 likely originated from a combination of an IncFII-type backbone and the blaNDM-5 flanking genetic elements.Conclusion: This is the first report of an ST5414 E. coli strain expressing an NDM-5 β-lactamase. This study highlights the genetic complexity of blaNDM-5 carrying plasmids and the urgent need for continuous active monitoring.Keywords: Escherichia coli, ST5415, NDM-5, IncFII, carbapenem resistant
- Published
- 2020
14. Phenotypic diversity and genetic complexity of <scp> PAX3 </scp> ‐related Waardenburg syndrome
- Author
-
Nutan Kamath, Dhanya Lakshmi Narayanan, Puneeth H. Somashekar, Priyanka Upadhyai, Shruti Bajaj, Katta M. Girisha, and Anju Shukla
- Subjects
Male ,0301 basic medicine ,Adolescent ,PAX3 ,030105 genetics & heredity ,Biology ,03 medical and health sciences ,Genetics ,medicine ,Humans ,Waardenburg Syndrome ,Child ,Waardenburg Syndrome Type 1 ,PAX3 Transcription Factor ,Genetics (clinical) ,Genetic complexity ,Waardenburg syndrome ,musculoskeletal system ,medicine.disease ,Microphthalmia-associated transcription factor ,Phenotype ,Pedigree ,030104 developmental biology ,Child, Preschool ,Mutation ,embryonic structures ,Female - Abstract
Waardenburg syndrome subtypes 1 and 3 are caused by pathogenic variants in PAX3. We investigated 12 individuals from four unrelated families clinically diagnosed with Waardenburg syndrome type 1/3. Novel pathogenic variants identified in PAX3 included single nucleotide variants (c.166C>T, c.829C>T), a 2-base pair deletion (c.366_367delAA) and a multi-exonic deletion. Two novel variants, c.166C>T and c.829C>T and a previously reported variant, c.256A>T in PAX3 were evaluated for their nuclear localization and ability to activate MITF promoter. The coexistence of two subtypes of Waardenburg syndrome with pathogenic variants in PAX3 and EDNRB was seen in one of the affected individuals. Multiple genetic diagnoses of Waardenburg syndrome type 3 and autosomal recessive deafness 1A was identified in an individual. We also review the phenotypic and genomic spectrum of individuals with PAX3-related Waardenburg syndrome reported in the literature.
- Published
- 2020
15. Genetic Complexity of the Human Genome in Health and Disease: Basic Concepts
- Author
-
A. Athanassiadou
- Subjects
Genetic complexity ,Statistical and Nonlinear Physics ,Human genome ,Disease ,Computational biology ,Biology ,Mathematical Physics - Abstract
Determination of the DNA sequence of the human genome, revealing extensive genetic variation, and the mapping of the genes and the various regulatory elements of genome function within the genomic DNA, has revolutionized the way we view the states of health and disease in our time. Genetic complexity of the genome is manifested on different levels. The first level refers to the expression of protein coding genes, as regulated by their individual promoter in linear proximity. The next level of genetic complexity involves long distance action by far away enhancers, interacting with promoters through DNA looping. This 3- dimensional (3D) regulation is further developing by chromosome folding into the so called transcription factories, for fully physiological expression. Chromosome folding, mediated by specific genetic elements - insulators - is adding to the genetic complexity by facilitating movements of chromatin of specific genomic regions - the so-called topologically associated domains (TAD) in support of transcription and other cellular functions. Further genetic complexity has emerged with the finding that over 75% of the genome is transcribed and except of the coding genes, a plethora of RNA transcripts are produced - the non-coding RNA - that has important regulatory roles in the gene expression context. The great variation of genome sequence and regulatory elements of the genome architecture are exploited in studies of genome-wide association with disease, in the framework of Precision Medicine and in general of Genomic Medicine.
- Published
- 2020
16. Nuclear DNA fractions with grossly different base ratios in the genome of the marine sponge Geodia cydonium
- Author
-
Bartmann-Lindholm, C., Geisert, M., Güngerich, U., Müller, W. E. G., Weinblum, D., Kremer, F., editor, Lagaly, G., editor, Jaenicke, R., editor, and Durchschlag, H., editor
- Published
- 1997
- Full Text
- View/download PDF
17. Selecting the optimum genetic background for transgenic varieties, with examples from Brassica
- Author
-
Lydiate, Derek, Dale, Phil, Lagercrantz, Ulf, Parkin, Isobel, Howell, Phil, Cassells, Alan C., editor, and Jones, Peter W., editor
- Published
- 1995
- Full Text
- View/download PDF
18. Using Machine Learning to Elucidate the Spatial and Genetic Complexity of the Ascending Aorta
- Author
-
Joyce C. Ho, Victor Nauffal, Puneet Batra, Samuel Friedman, Kenney Ng, S. A. Lubitz, Patrick T. Ellinor, Seung Hoan Choi, Mark E. Lindsay, Anthony A. Philippakis, Paolo Di Achille, Mahan Nekoui, and James P. Pirruccello
- Subjects
Genetic complexity ,Prioritization ,medicine.medical_specialty ,Aorta ,business.industry ,Sinotubular Junction ,medicine.disease ,Thoracic aortic aneurysm ,Stenosis ,Internal medicine ,medicine.artery ,Ascending aorta ,cardiovascular system ,medicine ,Cardiology ,Ventricular outflow tract ,business - Abstract
BackgroundThe left ventricular outflow tract (LVOT) and ascending aorta are spatially complex, with distinct pathologies and embryologic origins. Prior work examined genetics of thoracic aortic diameter in a single plane. We sought to elucidate the genetic basis for the diameter of the LVOT, the aortic root, and the ascending aorta.MethodsWe used deep learning to analyze 2.3 million cardiac magnetic resonance images from 43,317 UK Biobank participants. We computed the diameters of the LVOT, the aortic root, and at six locations in the ascending aorta. For each diameter, we conducted a genome-wide association study and generated a polygenic score. Finally, we investigated associations between these polygenic scores and disease incidence.Results79 loci were significantly associated with at least one diameter. Of these, 35 were novel, and a majority were associated with one or two diameters. A polygenic score of aortic diameter approximately 13mm from the sinotubular junction most strongly predicted thoracic aortic aneurysm in UK Biobank participants (n=427,016; HR=1.42 per standard deviation; CI=1.34-1.50, P=6.67×10−21). A polygenic score predicting a smaller aortic root was predictive of aortic stenosis (n=426,502; HR=1.08 per standard deviation; CI=1.03-1.12, P=5×10−6).ConclusionsWe detected distinct common genetic loci underpinning the diameters of the LVOT, the aortic root, and at several segments in the ascending aorta. We spatially defined a region of aorta whose genetics may be most relevant to predicting thoracic aortic aneurysm. We further described a genetic signature that may predispose to aortic stenosis. Understanding the genetic contributions to the diameter of the proximal aorta may enable identification of individuals at risk for life-threatening aortic disease and facilitate prioritization of therapeutic targets.
- Published
- 2021
19. Moving the Research Forward: The Best of British Biology Using the Tractable Model System Dictyostelium discoideum
- Author
-
Cornelis J. Weijer, Catherine J. Pears, Robin S.B. Williams, Robert H. Insall, Jonathan R. Chubb, Jason S. King, and Elinor Thompson
- Subjects
autophagy ,QH301-705.5 ,macropinocytosis ,Model system ,macromolecular substances ,Review ,social amoeba ,Models, Biological ,Dictyostelium discoideum ,slime mould ,Research model ,QH301 ,Drug Discovery ,Slime mold ,Animals ,Dictyostelium ,Biology (General) ,chemotaxis ,development ,Biology ,Organism ,Genetic complexity ,biology ,Research ,fungi ,phagocytosis ,General Medicine ,biology.organism_classification ,United Kingdom ,Evolutionary biology ,Protein Processing, Post-Translational - Abstract
The social amoeba Dictyostelium discoideum provides an excellent model for research across a broad range of disciplines within biology. The organism diverged from the plant, yeast, fungi and animal kingdoms around 1 billion years ago but retains common aspects found in these kingdoms. Dictyostelium has a low level of genetic complexity and provides a range of molecular, cellular, biochemical and developmental biology experimental techniques, enabling multidisciplinary studies to be carried out in a wide range of areas, leading to research breakthroughs. Numerous laboratories within the United Kingdom employ Dictyostelium as their core research model. This review introduces Dictyostelium and then highlights research from several leading British research laboratories, covering their distinct areas of research, the benefits of using the model, and the breakthroughs that have arisen due to the use of Dictyostelium as a tractable model system.
- Published
- 2021
20. A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity
- Author
-
J. Silvio Gutkind, Rachel A. O'Keefe, Jason F. Kreisberg, Jisoo Park, Dana J. Ramms, David Jimenez-Morales, Trey Ideker, Danielle L. Swaney, Helene Foussard, Fan Zheng, Michael J. McGregor, Jennifer R. Grandis, Kari A. Herrington, Natalia Jura, Yusuke Goto, Nan Jin, Mehdi Bouhaddou, Yan Zeng, Kyumin Kim, Margaret Soucheray, Daniel Johnson, Zhiyong Wang, Nevan J. Krogan, Min-Kyu Kim, John Von Dollen, Kirsten Obernier, Neil E. Bhola, and Nathan K. VanLandingham
- Subjects
Fibroblast Growth Factor ,Class I Phosphatidylinositol 3-Kinases ,General Science & Technology ,Nude ,Cell ,Mutant ,Drug Resistance ,Computational biology ,Biology ,medicine.disease_cause ,Article ,Cell Line ,Mice ,Rare Diseases ,Cell Movement ,Neoplasms ,Genetics ,medicine ,Animals ,Humans ,2.1 Biological and endogenous factors ,Protein Interaction Maps ,Dental/Oral and Craniofacial Disease ,Aetiology ,Head and neck ,Cancer ,Genetic complexity ,Mutation ,Tumor ,Multidisciplinary ,Carcinoma ,Microfilament Proteins ,Head and neck cancer ,Intracellular Signaling Peptides and Proteins ,A protein ,medicine.disease ,Xenograft Model Antitumor Assays ,medicine.anatomical_structure ,Squamous Cell ,Head and Neck Neoplasms ,Neoplasm ,Female ,Type 3 ,Protein Interaction Map ,Receptor - Abstract
Mapping protein interactions driving cancer Cancer is a genetic disease, and much cancer research is focused on identifying carcinogenic mutations and determining how they relate to disease progression. Three papers demonstrate how mutations are processed through networks of protein interactions to promote cancer (see the Perspective by Cheng and Jackson). Swaney et al . focus on head and neck cancer and identify cancer-enriched interactions, demonstrating how point mutant–dependent interactions of PIK3CA, a kinase frequently mutated in human cancers, are predictive of drug response. Kim et al . focus on breast cancer and identify two proteins functionally connected to the tumor-suppressor gene BRCA1 and two proteins that regulate PIK3CA. Zheng et al . developed a statistical model that identifies protein networks that are under mutation pressure across different cancer types, including a complex bringing together PIK3CA with actomyosin proteins. These papers provide a resource that will be helpful in interpreting cancer genomic data. —VV
- Published
- 2021
21. Co-variation of viral recombination with single nucleotide variants during virus evolution revealed by CoVaMa
- Author
-
Stephanea Sotcheff, Elizabeth Jaworski, Andrew Routh, Christian M. Gallardo, Bruce E. Torbett, and Shiyi Wang
- Subjects
Genetics ,Genetic complexity ,chemistry.chemical_classification ,Linkage disequilibrium ,chemistry ,Viral evolution ,Nucleotide ,Nanopore sequencing ,Co variation ,Biology ,Genome ,Recombination - Abstract
Adaptation of viruses to their environments occurs through the acquisition of both novel Single-Nucleotide Variants (SNV) and recombination events including insertions, deletions, and duplications. The co-occurrence of SNVs in individual viral genomes during their evolution has been well-described. However, unlike covariation of SNVs, studying the correlation between recombination events with each other or with SNVs has been hampered by their inherent genetic complexity and a lack of bioinformatic tools. Here, we expanded our previously reported CoVaMa pipeline (v0.1) to measure linkage disequilibrium between recombination events and SNVs within both short-read and long-read sequencing datasets. We demonstrate this approach using long-read nanopore sequencing data acquired from Flock House virus (FHV) serially passaged in vitro. We found SNVs that were either correlated or anti-correlated with large genomic deletions generated by nonhomologous recombination that give rise to Defective-RNAs. We also analyzed NGS data from longitudinal HIV samples derived from a patient undergoing antiretroviral therapy who proceeded to virological failure. We found correlations between insertions in the p6Gag and mutations in Gag cleavage sites. This report confirms previous findings and provides insights on novel associations between SNVs and specific recombination events within the viral genome and their role in viral evolution.
- Published
- 2021
22. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
- Author
-
Giefing, M., Wierzbicka, M., Szyfter, K., Brenner, J.C., Braakhuis, B.J., Brakenhoff, R.H., Bradford, C.R., Sorensen, J.A., Rinaldo, A., Rodrigo, J.P., Takes, R.P., and Ferlito, A.
- Subjects
- *
SQUAMOUS cell carcinoma , *HEAD tumors , *NECK tumors , *CYTOGENETICS , *DATABASE management , *GENETICS , *GENETIC techniques , *INFORMATION storage & retrieval systems , *MEDICAL databases , *PHYSICIANS , *DECISION making in clinical medicine , *DISEASE management , *MILLENNIALS , *ELECTRONIC health records , *INDIVIDUALIZED medicine , *SEQUENCE analysis , *TUMOR treatment - Abstract
Personalised medicine tumour boards, which leverage genomic data to improve clinical management, are becoming standard for the treatment of many cancers. This paper is designed as a primer to assist clinicians treating head and neck squamous cell carcinoma (HNSCC) patients with an understanding of the discovery and functional impact of recurrent genetic lesions that are likely to influence the management of this disease in the near future. This manuscript integrates genetic data from publicly available array comparative genome hybridization (aCGH) and next-generation sequencing genetics databases to identify the most common molecular alterations in HNSCC. The importance of these genetic discoveries is reviewed and how they may be incorporated into clinical care decisions is discussed. Considerations for the role of genetic stratification in the clinical management of head and neck cancer are maturing rapidly and can be improved by integrating data sets. This article is meant to summarise the discoveries made using multiple genomic platforms so that the head and neck cancer care provider can apply these discoveries to improve clinical care. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. The evolving genetic landscape of congenital disorders of glycosylation
- Author
-
Gert Matthijs and Matthew P. Wilson
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Glycosylation ,Biophysics ,Biology ,Biochemistry ,Genome ,DNA sequencing ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Congenital Disorders of Glycosylation ,Next generation sequencing ,Humans ,Molecular Biology ,Gene ,030304 developmental biology ,Genetic complexity ,Whole genome sequencing ,Genetics ,0303 health sciences ,Phenotype ,3. Good health ,Autosomal dominant ,chemistry ,030217 neurology & neurosurgery - Abstract
Congenital Disorders of Glycosylation (CDG) are an expanding and complex group of rare genetic disorders caused by defects in the glycosylation of proteins and lipids. The genetic spectrum of CDG is extremely broad with mutations in over 140 genes leading to a wide variety of symptoms ranging from mild to severe and life-threatening. There has been an expansion in the genetic complexity of CDG in recent years. More specifically several examples of alternate phenotypes in recessive forms of CDG and new types of CDG following an autosomal dominant inheritance pattern have been identified. In addition, novel genetic mechanisms such as expansion repeats have been reported and several already known disorders have been classified as CDG as their pathophysiology was better elucidated. Furthermore, we consider the future and outlook of CDG genetics, with a focus on exploration of the non-coding genome using whole genome sequencing, RNA-seq and multi-omics technology. ispartof: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS vol:1865 issue:11 ispartof: location:Netherlands status: published
- Published
- 2021
24. Clinically Important Phleboviruses and Their Detection in Human Samples
- Author
-
Amy J. Lambert and Holly R. Hughes
- Subjects
0301 basic medicine ,Phlebovirus ,viral detection ,030231 tropical medicine ,Computational biology ,Antibodies, Viral ,Microbiology ,03 medical and health sciences ,0302 clinical medicine ,phleboviruses ,Virology ,Medicine ,Animals ,Humans ,Viremia ,Phylogeny ,Genetic complexity ,biology ,business.industry ,Genetic Variation ,biology.organism_classification ,QR1-502 ,030104 developmental biology ,Infectious Diseases ,Phenuiviridae ,Phlebotomus Fever ,Commentary ,Psychodidae ,business ,human samples - Abstract
The detection of phleboviruses (family: Phenuiviridae) in human samples is challenged by the overall diversity and genetic complexity of clinically relevant strains, their predominantly nondescript clinical associations, and a related lack of awareness among some clinicians and laboratorians. Here, we seek to inform the detection of human phlebovirus infections by providing a brief introduction to clinically relevant phleboviruses, as well as key targets and approaches for their detection. Given the diversity of pathogens within the genus, this report focuses on diagnostic attributes that are generally shared among these agents and should be used as a complement to, rather than a replacement of, more detailed discussions on the detection of phleboviruses at the individual virus level.
- Published
- 2021
25. Oligogenic Causes of Human Differences of Sex Development: Facing the Challenge of Genetic Complexity
- Author
-
Grit Sommer, Christa E. Flück, and Chrysanthi Kouri
- Subjects
Genetic complexity ,Endocrinology ,Evolutionary biology ,Endocrinology, Diabetes and Metabolism ,Pediatrics, Perinatology and Child Health ,Biology ,610 Medicine & health - Abstract
Background: Deviations of intrauterine sex determination and differentiation and postnatal sex development can result in a very heterogeneous group of differences of sex development (DSD) with a broad spectrum of phenotypes. Variants in genes involved in sexual development cause different types of DSD, but predicting the phenotype from an individual’s genotype and vice versa remains challenging. Summary: Next Generation Sequencing (NGS) studies suggested that oligogenic inheritance contributes to the broad manifestation of DSD phenotypes. This review will focus on possible oligogenic inheritance in DSD identified by NGS studies with a special emphasis on NR5A1variants as an example of oligogenic origin associated with a broad range of DSD phenotypes. We thoroughly searched the literature for evidence regarding oligogenic inheritance in DSD diagnosis with NGS technology and describe the challenges to interpret contribution of these genes to DSD phenotypic variability and pathogenicity. Key Messages: Variants in common DSD genes like androgen receptor (AR), mitogen-activated protein kinase kinase kinase 1 (MAP3K1), Hydroxy-Delta-5-Steroid Dehydrogenase 3 Beta- And Steroid Delta-Isomerase 2 (HSD3B2), GATA Binding Protein 4 (GATA4), zinc finger protein friend of GATA family member 2 (ZFPM2), 17b-hydroxysteroid dehydrogenase type 3 (HSD17B3), mastermind-like domain-containing protein 1 (MAMLD1), and nuclear receptor subfamily 5 group A member 1 (NR5A1) have been detected in combination with additional variants in related genes in DSD patients with a broad range of phenotypes, implying a role of oligogenic inheritance in DSD, while still awaiting proof. Use of NGS approach for genetic diagnosis of DSD patients can reveal more complex genetic traits supporting the concept of oligogenic cause of DSD. However, assessing the pathomechanistic contribution of multiple gene variants on a DSD phenotype remains an unsolved conundrum.
- Published
- 2021
26. The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders
- Author
-
Qingyang Xiao and Volker M. Lauschke
- Subjects
0301 basic medicine ,Genetics ,Genetic complexity ,medicine.medical_specialty ,Molecular medicine ,Public health ,Disease ,QH426-470 ,030105 genetics & heredity ,Biology ,Article ,03 medical and health sciences ,030104 developmental biology ,Risk factors ,Molecular genetics ,Epidemiology ,medicine ,Medicine ,Genetic variability ,Molecular Biology ,Gene ,Genetics (clinical) ,Founder effect - Abstract
Autosomal recessive (AR) disorders pose a significant burden for public health. However, despite their clinical importance, epidemiology and molecular genetics of many AR diseases remain poorly characterized. Here, we analyzed the genetic variability of 508 genes associated with AR disorders based on sequencing data from 141,456 individuals across seven ethnogeographic groups by integrating variants with documented pathogenicity from ClinVar, with stringent functionality predictions for variants with unknown pathogenicity. We first validated our model using 85 diseases for which population-specific prevalence data were available and found that our estimates strongly correlated with the respective clinically observed disease frequencies (r = 0.68; p 25 additional population-specific founder mutations. The presented analyses reveal the molecular genetics of AR diseases with unprecedented resolution and provide insights into epidemiology, complexity, and population-specific founder effects. These data can serve as a powerful resource for clinical geneticists to inform population-adjusted genetic screening programs, particularly in otherwise understudied ethnogeographic groups.
- Published
- 2021
27. Comparative genomics and transcriptomics analyses reveal genetic complexity of soybean anthracnose caused by >i<Colletotrichum>/i< species
- Author
-
Thaís Regina Boufleur
- Subjects
Comparative genomics ,Genetics ,Genetic complexity ,Transcriptome ,biology ,Effector ,Plant defense against herbivory ,Colletotrichum species ,Colletotrichum orchidearum ,Colletotrichum truncatum ,biology.organism_classification - Published
- 2021
28. A look of paternal ancestry in a sample of Ecuadorian 'MESTIZO' population analyzed through PowerPlex Y23
- Author
-
Ma. Toscano, G. Burgos, C. Ávila, A. Garzón-Salazar, Km. Maldonado-Uquillas, and Elius Paz-Cruz
- Subjects
Genetic complexity ,education.field_of_study ,010401 analytical chemistry ,Population ,Haplotype ,Ethnic group ,Sample (statistics) ,Biology ,01 natural sciences ,humanities ,Haplogroup ,0104 chemical sciences ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Evolutionary biology ,Genetics ,Y-STR ,030216 legal & forensic medicine ,education - Abstract
Ecuadorian population is mainly composed of Mestizos, an ethnic group whose origins date back to admixture events in post-Columbian periods, including Amerindians, Europeans, and Africans. Hence, it is important to elucidate its genetic complexity thus increasing Ecuadorian registers in local and global databases, aiding in future forensic analysis and evolutionary studies. We analyzed 101 haplotypes of self-determined Mestizo male individuals by the PowerPlex Y23 System. Haplogroup assignment was evaluated by comparing three Y-STR haplogroup in silico algorithms. Ninety-nine haplotypes were found to be unique; therefore, the haplotype diversity for this population was 0.9998 +/− 0.0014. By means of haplogroup prediction we found native lineages (41%), and non-native-American lineages (59%). The comparison between predictors showed similar haplogroup assignments; however, some samples predictions were ambiguous.
- Published
- 2019
29. A Resurrected Scenario : Single Gain and Massive Loss of Nitrogen-Fixing Nodulation
- Author
-
René Geurts, Jeff J. Doyle, and Robin van Velzen
- Subjects
0106 biological sciences ,0301 basic medicine ,Root nodule ,Frankia ,Energetic cost ,Plant Science ,Biology ,Genes, Plant ,rhizobia ,Plant Root Nodulation ,01 natural sciences ,Rhizobia ,03 medical and health sciences ,Nitrogen Fixation ,evolution ,Laboratorium voor Moleculaire Biologie ,Symbiosis ,Phylogeny ,Plant Physiological Phenomena ,Genetic complexity ,nitrogen-fixing root nodules ,Endosymbiosis ,Plants ,biology.organism_classification ,Biological Evolution ,030104 developmental biology ,Evolutionary biology ,Nitrogen fixation ,Laboratory of Molecular Biology ,EPS ,010606 plant biology & botany - Abstract
Root nodule endosymbiosis with nitrogen-fixing bacteria provides plants with unlimited access to fixed nitrogen, but at a significant energetic cost. Nodulation is generally considered to have originated in parallel in different lineages, but this hypothesis downplays the genetic complexity of nodulation and requires independent recruitment of many common features across lineages. Recent phylogenomic studies revealed that genes that function in establishing or maintaining nitrogen-fixing nodules are independently lost in non-nodulating relatives of nitrogen-fixing plants. In our opinion, these data are best explained by a scenario of a single gain followed by massively parallel loss of nitrogen-fixing root nodules triggered by events at geological scale.
- Published
- 2019
30. Salt stress under the scalpel – dissecting the genetics of salt tolerance
- Author
-
Mitchell J. L. Morton, Stephanie Saade, Mark Tester, Mariam Awlia, Sónia Negrão, Yveline Pailles, and Nadia Al-Tamimi
- Subjects
Crops, Agricultural ,0106 biological sciences ,0301 basic medicine ,Soil salinity ,Salt (cryptography) ,Quantitative Trait Loci ,Genomics ,Plant Science ,Biology ,Crop species ,Salt Stress ,01 natural sciences ,03 medical and health sciences ,Stress, Physiological ,SI Genome to Phenome ,Genetics ,Domestication ,Genetic complexity ,business.industry ,Salt Tolerance ,Cell Biology ,Forward genetics ,Phenotype ,030104 developmental biology ,Agriculture ,business ,010606 plant biology & botany - Abstract
Summary Salt stress limits the productivity of crops grown under saline conditions, leading to substantial losses of yield in saline soils and under brackish and saline irrigation. Salt tolerant crops could alleviate these losses while both increasing irrigation opportunities and reducing agricultural demands on dwindling freshwater resources. However, despite significant efforts, progress towards this goal has been limited, largely because of the genetic complexity of salt tolerance for agronomically important yield‐related traits. Consequently, the focus is shifting to the study of traits that contribute to overall tolerance, thus breaking down salt tolerance into components that are more genetically tractable. Greater consideration of the plasticity of salt tolerance mechanisms throughout development and across environmental conditions furthers this dissection. The demand for more sophisticated and comprehensive methodologies is being met by parallel advances in high‐throughput phenotyping and sequencing technologies that are enabling the multivariate characterisation of vast germplasm resources. Alongside steady improvements in statistical genetics models, forward genetics approaches for elucidating salt tolerance mechanisms are gaining momentum. Subsequent quantitative trait locus and gene validation has also become more accessible, most recently through advanced techniques in molecular biology and genomic analysis, facilitating the translation of findings to the field. Besides fuelling the improvement of established crop species, this progress also facilitates the domestication of naturally salt tolerant orphan crops. Taken together, these advances herald a promising era of discovery for research into the genetics of salt tolerance in plants., Significance Statement The improvement of salt tolerance in crops is imperative for addressing yield penalties in saline soils and enabling the use of brackish water for irrigation. Major advances in high‐throughput phenotyping, data analysis, sequencing technologies and statistical genetics are empowering investigations into the mechanisms and genetics of salt tolerance, drawing upon an ever‐expanding suite of genetic resources. Bridging the genotype–phenotype gap to gain insights into the mechanisms of salt tolerance in plants is becoming practical.
- Published
- 2019
31. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.
- Author
-
Black, P. A., de Vos, M., Louw, G. E., van der Merwe, R. G., Dippenaar, A., Streicher, E. M., Abdallah, A. M., Sampson, S. L., Victor, T. C., Dolby, T., Simpson, J. A., van Helden, P. D., Warren, R. M., and Pain, A.
- Subjects
- *
GENOMICS , *ANTIBIOTICS , *MYCOBACTERIUM tuberculosis , *DRUG resistance in bacteria , *BACTERIAL population , *DNA , *RIFAMPIN - Abstract
Background: Whole genome sequencing has revolutionised the interrogation of mycobacterial genomes. Recent studies have reported conflicting findings on the genomic stability of Mycobacterium tuberculosis during the evolution of drug resistance. In an age where whole genome sequencing is increasingly relied upon for defining the structure of bacterial genomes, it is important to investigate the reliability of next generation sequencing to identify clonal variants present in a minor percentage of the population. This study aimed to define a reliable cut-off for identification of low frequency sequence variants and to subsequently investigate genetic heterogeneity and the evolution of drug resistance in M. tuberculosis. Methods: Genomic DNA was isolated from single colonies from 14 rifampicin mono-resistant M. tuberculosis isolates, as well as the primary cultures and follow up MDR cultures from two of these patients. The whole genomes of the M. tuberculosis isolates were sequenced using either the Illumina MiSeq or Illumina HiSeq platforms. Sequences were analysed with an in-house pipeline. Results: Using next-generation sequencing in combination with Sanger sequencing and statistical analysis we defined a read frequency cut-off of 30 % to identify low frequency M. tuberculosis variants with high confidence. Using this cut-off we demonstrated a high rate of genetic diversity between single colonies isolated from one population, showing that by using the current sequencing technology, single colonies are not a true reflection of the genetic diversity within a whole population and vice versa. We further showed that numerous heterogeneous variants emerge and then disappear during the evolution of isoniazid resistance within individual patients. Our findings allowed us to formulate a model for the selective bottleneck which occurs during the course of infection, acting as a genomic purification event. Conclusions: Our study demonstrated true levels of genetic diversity within an M. tuberculosis population and showed that genetic diversity may be re-defined when a selective pressure, such as drug exposure, is imposed on M. tuberculosis populations during the course of infection. This suggests that the genome of M. tuberculosis is more dynamic than previously thought, suggesting preparedness to respond to a changing environment. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
32. Genetic and Environmental Architecture of Changes in Episodic Memory From Middle to Late Middle Age.
- Author
-
Panizzon, Matthew S., Neale, Michael C., Docherty, Anna R., Franz, Carol E., Jacobson, Kristen C., Toomey, Rosemary, Hong Xian, Vasilopoulos, Terrie, Rana, Brinda K., McKenzie, Ruth, Lyons, Michael J., and Kremen, William S.
- Subjects
- *
EPISODIC memory , *GENETIC correlations , *COGNITIVE ability , *RECOLLECTION (Psychology) , *VARIANCES - Abstract
Episodic memory is a complex construct at both the phenotypic and genetic level. Ample evidence supports age-related cognitive stability and change being accounted for by general and domain specific factors. We hypothesized that general and specific factors would underlie change even within this single cognitive domain. We examined 6 measures from 3 episodic memory tests in a narrow age cohort at middle and late middle age. The factor structure was invariant across occasions. At both time points 2 of 3 test-specific factors (story recall, design recall) had significant genetic influences independent of the general memory factor. Phenotypic stability was moderate to high, and primarily accounted for by genetic influences, except for 1 test-specific factor (list learning). Mean change over time was nonsignificant for 1 test-level factor; 1 declined; 1 improved. The results highlight the phenotypic and genetic complexity of memory and memory change, and shed light on an understudied period of life. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
33. Back to the future: implications of genetic complexity for the structure of hybrid breeding programs
- Author
-
Mark E. Cooper, Frank Technow, and Dean Podlich
- Subjects
0106 biological sciences ,Germplasm ,Crops, Agricultural ,AcademicSubjects/SCI01140 ,AcademicSubjects/SCI00010 ,breeding strategies ,Context (language use) ,historical properties ,Biology ,AcademicSubjects/SCI01180 ,01 natural sciences ,Zea mays ,03 medical and health sciences ,Effective population size ,Genetic variation ,Genetics ,genetic complexity ,Molecular Biology ,Genetics (clinical) ,Selection (genetic algorithm) ,030304 developmental biology ,Investigation ,0303 health sciences ,hybrid breeding ,long-term genetic gain ,Quantitative genetics ,Genetic architecture ,NK model ,Plant Breeding ,Risk analysis (engineering) ,AcademicSubjects/SCI00960 ,010606 plant biology & botany - Abstract
Commercial hybrid breeding operations can be described as decentralized networks of smaller, more or less isolated breeding programs. There is further a tendency for the disproportionate use of successful inbred lines for generating the next generation of recombinants, which has led to a series of significant bottlenecks, particularly in the history of the North American and European maize germplasm. Both the decentralization and the disproportionate contribution of inbred lines reduce effective population size and constrain the accessible genetic space. Under these conditions, long-term response to selection is not expected to be optimal under the classical infinitesimal model of quantitative genetics. In this study, we therefore aim to propose a rationale for the success of large breeding operations in the context of genetic complexity arising from the structure and properties of interactive genetic networks. For this, we use simulations based on the NK model of genetic architecture. We indeed found that constraining genetic space through program decentralization and disproportionate contribution of parental inbred lines, is required to expose additive genetic variation and thus facilitate heritable genetic gains under high levels of genetic complexity. These results introduce new insights into why the historically grown structure of hybrid breeding programs was successful in improving the yield potential of hybrid crops over the last century. We also hope that a renewed appreciation for “why things worked” in the past can guide the adoption of novel technologies and the design of future breeding strategies for navigating biological complexity.
- Published
- 2021
34. Genetic complexity impacts the clinical outcome of follicular lymphoma patients
- Author
-
Alejandro Medina, Luis G Díaz, M. Carmen Chillón, María García-Álvarez, Alejandro Martín, Pilar Tamayo, Sara Alonso-Álvarez, Isabel Prieto-Conde, Carmen López Esteban, Pedro Blanco, Cristina Jiménez, Oscar Blanco, M. Dolores Caballero, M. Eugenia Sarasquete, Marcos González, Ana Balanzategui, Alicia Antón, Ramón García-Sanz, Miguel Alcoceba, Rebeca Maldonado, Verónica González-Calle, Noemi Puig, Marta Rodríguez, Norma C. Gutiérrez, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (España), Junta de Castilla y León, Asociación Española Contra el Cáncer, Fundacion de la Sociedad Española de Hematología y Hemoterapia, and European Commission
- Subjects
Genetic complexity ,Oncology ,medicine.medical_specialty ,Lymphoid Neoplasia ,B-cell lymphoma ,business.industry ,MEDLINE ,Follicular lymphoma ,Hematology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,lcsh:RC254-282 ,Outcome (game theory) ,Translocation, Genetic ,Text mining ,Internal medicine ,Genetics research ,Humans ,Medicine ,business ,Lymphoma, Follicular - Abstract
© The Author(s) 2021., Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma (NHL, 20–30%) after diffuse large B-cell lymphoma (DLBCL). Despite the introduction of rituximab and the high response rate to first-line treatment, approximately 20% of the FL patients relapse or progress within 2 years of receiving first-line therapy. Therefore, the major challenge is finding biomarkers that identify high-risk patients at diagnosis., This work was partially supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness PI15/01393, PI18/00410, CIBERONC-CB16/12/00233, and “Una manera de hacer Europa” (Innocampus; CEI-2010-1-0010)”, the Education Council or Health Council of the Junta de Castilla y León (CAS102P17, GRS 1180/A/15), Spanish Association Against Cancer (AECC; PROYE18020BEA), and Gilead Sciences (GLD17/00334). CJ, MES, and AMe are supported by the ISCII (CD19/00030, CPII18/00028, and FI19/00320). MGA, IPC, and CJ were supported by the Spanish Society of Hematology Foundation (FEHH). All Spanish funding is co-sponsored by the European Union FEDER program.
- Published
- 2021
35. Next-generation microbiology: from comparative genomics to gene function
- Author
-
Samuel K. Sheppard, Carolin M. Kobras, and Andy Fenton
- Subjects
Microbiological Techniques ,QH301-705.5 ,media_common.quotation_subject ,Review ,Biology ,QH426-470 ,Microbiology ,03 medical and health sciences ,Molecular microbiology ,Genetics ,Turning point ,Biology (General) ,Function (engineering) ,Genetic Association Studies ,030304 developmental biology ,media_common ,Genetic complexity ,Comparative genomics ,0303 health sciences ,Bacteria ,030306 microbiology ,Genetic Variation ,Genomics ,Mutagenesis, Insertional ,Conceptual framework ,Gene Expression Regulation ,DNA Transposable Elements ,Metagenome ,Genetic Fitness ,Metagenomics ,Genome-Wide Association Study - Abstract
Microbiology is at a turning point in its 120-year history. Widespread next-generation sequencing has revealed genetic complexity among bacteria that could hardly have been imagined by pioneers such as Pasteur, Escherich and Koch. This data cascade brings enormous potential to improve our understanding of individual bacterial cells and the genetic basis of phenotype variation. However, this revolution in data science cannot replace established microbiology practices, presenting the challenge of how to integrate these new techniques. Contrasting comparative and functional genomic approaches, we evoke molecular microbiology theory and established practice to present a conceptual framework and practical roadmap for next-generation microbiology. Supplementary Information The online version contains supplementary material available at 10.1186/s13059-021-02344-9.
- Published
- 2021
36. Neuroradiologic Phenotyping of Galactosemia: From the Neonatal Form to the Chronic Stage
- Author
-
James Davison, Daniela Longo, L.L.F. do Amaral, E. Bevivino, Felipe Torres Pacheco, M.C. Rossi-Espagnet, Matheus Dorigatti Soldatelli, A.J. da Rocha, S. Sudhakar, P. Hanagandi, A.L. Petengill, Kshitij Mankad, and E. Fontana
- Subjects
In vivo magnetic resonance spectroscopy ,Galactosemias ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Disease ,Clinical onset ,030218 nuclear medicine & medical imaging ,White matter ,03 medical and health sciences ,0302 clinical medicine ,metabolic ,Edema ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,galactosemia, mri, metabolic ,Child ,mri ,galactosemia ,Genetic complexity ,Chronic stage ,business.industry ,Galactosemia ,Infant, Newborn ,Brain ,Infant ,medicine.disease ,medicine.anatomical_structure ,Child, Preschool ,Disease Progression ,Female ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Galactosemia is a rare genetic condition caused by mutation of enzymes involved in galactose and glucose metabolism. The varying clinical spectrum reflects the genetic complexity of this entity manifesting as acute neonatal toxicity syndrome, requiring prompt diagnosis and treatment, to more insidious clinical scenarios as observed in the subacute and chronic presentations. The current literature predominantly focuses on the long-standing sequelae of this disease. The purpose of this multicenter clinical report comprising 17 patients with galactosemia is to highlight the MR imaging patterns encompassing the whole spectrum of galactosemia, emphasizing the 3 main clinical subtypes: 1) acute neonatal presentation, with predominant white matter edema; 2) subacute clinical onset with a new finding called the "double cap sign"; and 3) a chronic phase of the disease with heterogeneous imaging findings. The knowledge of these different patterns together with MR spectroscopy and the clinical presentation may help in prioritizing galactosemia over other neonatal metabolic diseases and prevent possible complications.
- Published
- 2021
37. The Genetic Complexity of Prostate Cancer
- Author
-
Gabriel Wasinger, Renate Kain, Eva Compérat, Geraldine Cancel-Tassin, Olivier Cussenot, André Oszwald, Centre de Recherche pour les Pathologies Prostatiques [Paris] (CeRePP), Sorbonne Université (SU), Service de Pathologie [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Medizinische Universität Wien = Medical University of Vienna, Sorbonne Université - Faculté de Médecine (SU FM), and Service d'urologie [CHU Tenon]
- Subjects
0301 basic medicine ,Male ,PTEN ,lcsh:QH426-470 ,[SDV]Life Sciences [q-bio] ,Computational biology ,Review ,Biology ,urologic and male genital diseases ,TMPRSS2 ,Germline ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Germline mutation ,Genetics ,medicine ,Humans ,Genetics (clinical) ,Genetic complexity ,Prostatic Neoplasms ,Genomics ,medicine.disease ,prostate cancer ,3. Good health ,lcsh:Genetics ,androgen receptors ,030104 developmental biology ,030220 oncology & carcinogenesis ,ERG ,Mutation ,biology.protein ,germline mutations ,somatic mutations ,Signal Transduction - Abstract
International audience; Prostate cancer (PCa) is a major concern in public health, with many genetically distinct subsets. Genomic alterations in PCa are extraordinarily complex, and both germline and somatic mutations are of great importance in the development of this tumor. The aim of this review is to provide an overview of genetic changes that can occur in the development of PCa and their role in potential therapeutic approaches. Various pathways and mechanisms proposed to play major roles in PCa are described in detail to provide an overview of current knowledge.
- Published
- 2020
38. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
- Author
-
Daniel Schwendenwein, Klaus Schliep, Vida Ungerer, Ingund Rosales Rodriguez, Abel Jacobus Bronkhorst, Christoph Wilhelm Sensen, Stefan Holdenrieder, and Stefan Grabuschnig
- Subjects
Population ,Review ,Computational biology ,Biology ,Genome ,Catalysis ,Specimen Handling ,Inorganic Chemistry ,cell-free DNA ,lcsh:Chemistry ,circulating DNA ,liquid biopsy ,circulating tumor DNA ,active release of cfDNA ,passive release of cfDNA ,origins of cfDNA ,chemistry.chemical_compound ,Neoplasms ,Nucleic Acids ,Biomarkers, Tumor ,Animals ,Humans ,Physical and Theoretical Chemistry ,Liquid biopsy ,education ,Molecular Biology ,lcsh:QH301-705.5 ,Spectroscopy ,Genetic complexity ,education.field_of_study ,Organic Chemistry ,General Medicine ,ddc ,Computer Science Applications ,Cell-free fetal DNA ,chemistry ,lcsh:Biology (General) ,lcsh:QD1-999 ,Nucleic acid ,Circulating DNA ,Cell-Free Nucleic Acids ,DNA - Abstract
Through various pathways of cell death, degradation, and regulated extrusion, partial or complete genomes of various origins (e.g., host cells, fetal cells, and infiltrating viruses and microbes) are continuously shed into human body fluids in the form of segmented cell-free DNA (cfDNA) molecules. While the genetic complexity of total cfDNA is vast, the development of progressively efficient extraction, high-throughput sequencing, characterization via bioinformatics procedures, and detection have resulted in increasingly accurate partitioning and profiling of cfDNA subtypes. Not surprisingly, cfDNA analysis is emerging as a powerful clinical tool in many branches of medicine. In addition, the low invasiveness of longitudinal cfDNA sampling provides unprecedented access to study temporal genomic changes in a variety of contexts. However, the genetic diversity of cfDNA is also a great source of ambiguity and poses significant experimental and analytical challenges. For example, the cfDNA population in the bloodstream is heterogeneous and also fluctuates dynamically, differs between individuals, and exhibits numerous overlapping features despite often originating from different sources and processes. Therefore, a deeper understanding of the determining variables that impact the properties of cfDNA is crucial, however, thus far, is largely lacking. In this work we review recent and historical research on active vs. passive release mechanisms and estimate the significance and extent of their contribution to the composition of cfDNA.
- Published
- 2020
39. Gene expression-based clinical predictions in lung adenocarcinoma
- Author
-
Yangbo Feng, Yong Han, Jie Lei, Yanlu Xiong, Jinbo Zhao, Tianyun Qiao, Yongsheng Zhou, and Tao Jiang
- Subjects
Aging ,Lung Neoplasms ,recurrence ,Adenocarcinoma of Lung ,Computational biology ,Biology ,survival ,Bioconductor ,models ,Survival probability ,Gene expression ,medicine ,Humans ,Gene ,Neoplasm Staging ,Genetic complexity ,String database ,Proportional hazards model ,Computational Biology ,Cell Biology ,medicine.disease ,Prognosis ,lung adenocarcinoma ,Gene Expression Regulation, Neoplastic ,Survival Rate ,gene expression ,Adenocarcinoma ,Research Paper - Abstract
Mining disease-related genes contributes momentously to handling lung adenocarcinoma (LUAD). But genetic complexity and tumor heterogeneity severely get in the way. Fortunately, new light has been shed by dramatic progress of bioinformatic technology in the past decades. In this research, we investigated relationships between gene expression and clinical features of LUAD via integrative bioinformatic analysis. First, we applied limma and DESeq2 packages to analyze differentially expressed genes (DEGs) of LUAD from GEO database and TCGA project (tumor tissues versus normal tissues), and acquired 180 down-regulated DEGs and 52 up-regulated DEGs. Then, we investigated genetic and biological assignment of theses DEGs by Bioconductor packages and STRING database. We found these DEGs were distributed dispersedly among chromosomes, enriched observably in extracellular matrix-related processes, and weighted hierarchically in interaction network. Finally, we established DEGs-based statistical models for evaluating TNM stage and survival status of LUAD. And these models (logistic regression models for TNM parameter and Cox regression models for survival probability) all possessed fine predictive efficacy (C-indexes: T, 0.740; N, 0.687; M, 0.823; overall survival, 0.678; progression-free survival, 0.611). In summary, we have successfully established gene expression-based models for assessing clinical characteristics of LUAD, which will assist its pathogenesis investigation and clinical intervention.
- Published
- 2020
40. Anopheles stephensi as an emerging malaria vector in the Horn of Africa with high susceptibility to Ethiopian Plasmodium vivax and Plasmodium falciparum isolates
- Author
-
Chris Drakeley, Endalamaw Gadisa, Endashaw Esayas, Thomas Walker, Eyuel Asemahegn Bogale, Surafel K Tebeje, Hiwot Teka, Thomas S. Churcher, Sheleme Chibsa, Elifaged Hailemeskel, Matthew Murphy, Claire L. Jeffries, Kjerstin Lanke, Temesgen Tafesse, Roel Heutink, Wakweya Chali, Louisa A. Messenger, Jan Kolaczinski, Gedeon Yohannes, Abrham Gashaw, Fitsum G. Tadesse, Teun Bousema, Soriya Kedir, Girma Shumie, Tizita Tsegaye, Senya Asfer Sabir, Dereje Dengela, Sinknesh Wolde Behaksra, Lisette Meerstein-Kessel, Temesgen Ashine, Anne L. Wilson, Seth R. Irish, Meshesha Balkew, Kigozi Simon, Daniel Mekonnen, Peter Mumba, and Tadele Emiru
- Subjects
2. Zero hunger ,Genetic complexity ,0303 health sciences ,biology ,030231 tropical medicine ,Plasmodium vivax ,fungi ,Plasmodium falciparum ,biology.organism_classification ,Blood meal ,medicine.disease ,Virology ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,stomatognathic system ,parasitic diseases ,medicine ,Malaria vector ,Malaria control ,Anopheles stephensi ,Malaria ,030304 developmental biology - Abstract
Anopheles stephensi, an efficient Asian malaria vector, recently spread into the Horn of Africa and may increase malaria receptivity in African urban areas. We assessed occurrence, genetic complexity, blood meal source and infection status of An. stephensi in Awash Sebat Kilo town, Ethiopia. We used membrane feeding assays to assess competence of local An. stephensi to P. vivax and P. falciparum isolates from clinical patients. 75.3% of the examined waterbodies were infested with An. stephensi developmental stages that were genetically closely related to isolates from Djibouti and Pakistan. Both P. vivax and P. falciparum were detected in wild-caught adult An. stephensi. Local An. stephensi was more receptive to P. vivax compared to a colony of An. arabiensis. We conclude that An. stephensi is an established vector in this part of Ethiopia, highly permissive for local P. vivax and P. falciparum isolates and presents an important new challenge for malaria control.Summary of the articleAn. stephensi, a metropolitan malaria vector that recently expanded to the Horn of African, was highly susceptible to local P. falciparum and P. vivax isolates from Ethiopia and may increase malariogenic potential of rapidly expanding urban settings in Africa.
- Published
- 2020
- Full Text
- View/download PDF
41. Estimation of Genetic Diversity in Seven Races of Native Maize from the Highlands of Mexico
- Author
-
Pedro Antonio López, Amalio Santacruz-Varela, J. Jesús García-Zavala, Fernando Castillo-González, Aurelio Hernández-Bautista, Mario Rocandio-Rodríguez, Ricardo Lobato-Ortiz, Higinio López-Sánchez, and Leobigildo Córdova-Téllez
- Subjects
0106 biological sciences ,Germplasm ,combined analysis ,Biology ,01 natural sciences ,lcsh:Agriculture ,Genetic resources ,evolution ,Genetic complexity ,Genetic diversity ,Phylogenetic tree ,lcsh:S ,food and beverages ,04 agricultural and veterinary sciences ,germplasm ,Zea mays ,genetic resources ,Evolutionary biology ,zea mays ,Principal component analysis ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Microsatellite ,Agronomy and Crop Science ,human activities ,010606 plant biology & botany - Abstract
Characterizing the genetic diversity of maize (Zea mays L.) populations by their morphological and molecular attributes makes it possible to place populations into specific groups, thus, facilitating the design of procedures for their optimum and sustainable use. In this study, data from two lines of evidence were analyzed simultaneously to robustly classify maize populations and to determine their genetic relationships. Seven maize races of the central high plateau of Mexico were characterized using a combined analysis of 13 morphological traits and 31 microsatellite loci. The germplasm assessed included samples of 119 accessions held at Mexican germplasm banks. Cluster and principal component analyses were performed. Also, genetic and geographic relationships among the accessions were determined. Principal component analysis separated the different accessions into well-defined groups using first three principal components. The accessions of Arrocillo Amarillo and Elotes Có, nicos races did not exhibit a grouping pattern, indicating greater genetic complexity. Better grounded grouping and phylogenetic relationships were obtained when traits of both lines of evidence were used simultaneously.
- Published
- 2020
42. Using Two- and Three-Dimensional Human iPSC Culture Systems to Model Psychiatric Disorders
- Author
-
Kimberly M. Christian, Guo Li Ming, and Hongjun Song
- Subjects
0301 basic medicine ,Genetic complexity ,medicine.medical_specialty ,Medication history ,business.industry ,Disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Drug development ,medicine ,Postmortem tissue ,Genetic risk ,Psychiatry ,Induced pluripotent stem cell ,business ,030217 neurology & neurosurgery ,Brain function - Abstract
Psychiatric disorders are among the most challenging human diseases to understand at a mechanistic level due to the heterogeneity of symptoms within established diagnostic categories, the general absence of focal pathology, and the genetic complexity inherent in these mostly polygenic disorders. Each of these features presents unique challenges to disease modeling for biological discovery, drug development, or improved diagnostics. In addition, live human neural tissue has been largely inaccessible to experimentation, leaving gaps in our knowledge derived from animal models that cannot fully recapitulate the features of the disease, indirect measures of brain function in human patients, and from analyses of postmortem tissue that can be confounded by comorbid conditions and medication history.
- Published
- 2020
43. Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation
- Author
-
Luciana Moreira, Olga Amaral, Ana Joana Duarte, José Bragança, Renato Santos, and Diogo Ribeiro
- Subjects
0301 basic medicine ,Male ,Cell type ,Induced Pluripotent Stem Cells ,Lysosomal storage disorders ,Disease ,Biology ,medicine.disease_cause ,Biologia Molecular e Celular ,03 medical and health sciences ,0302 clinical medicine ,Lysosomal Disorders ,medicine ,Humans ,Induced pluripotent stem cell ,lcsh:QH301-705.5 ,Genétca Humana ,Cell Models ,Modelos Celulares ,Genetic complexity ,Hemizygote ,Mutation ,Human Genetics ,Cell Biology ,General Medicine ,medicine.disease ,Fabry disease ,Doenças Genéticas ,030104 developmental biology ,lcsh:Biology (General) ,alpha-Galactosidase ,Cancer research ,Fabry Disease ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
O trabalho foi desenvolvido no DGH do INSA em colaboração com participantes do DGH do Porto e de Lisboa ao abrigo do projeto PTDC/BIM-MEC/4762/2014. Fabry Disease (FD) is a multisystemic X-linked disorder that belongs to the group of lysosomal storage disorders (LSDs). Causal mutations on alpha-galactosidase A (α-Gal A) commonly lead to abnormal protein and consequently to FD. Since it is an X-linked disease, males are primarily affected. This work describes the generation of induced Pluripotent Stem Cells (iPSCs) from skin fibroblasts from a FD patient, using non-integrative episomal vectors. Differentiation of iPSCs can be applied to generate a variety of cell types with high degree of genetic complexity that would otherwise be difficult to obtain. Portuguese Foundation of Science and Technology (FCT) project PTDC/BIM-MEC/4762/2014 (PI-O.A.) and UIDB/00211/2020. R.S. was the recipient of an FCT Grant from project PTDC/BIM-MEC/4762/2014 (MCTES). info:eu-repo/semantics/publishedVersion
- Published
- 2020
44. Speciation and periodic restricted environments. The case of genus Ononis L. (subsections Natrix and Viscosae)
- Author
-
Valdemar Carnide, Antonio L. Crespí, João Rocha, Francisco Amich, C. Costa, Isaura Castro, Gisela Costa, and Rubén Ramírez-Rodríguez
- Subjects
0106 biological sciences ,0301 basic medicine ,Environmental dynamics ,Genetic complexity ,biology ,Haplotype ,Introgression ,Plant Science ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Gene flow ,Natrix ,03 medical and health sciences ,030104 developmental biology ,Taxon ,Evolutionary biology ,Ononis ,Ecology, Evolution, Behavior and Systematics - Abstract
The morpho–environmental similarity between subsections Natrix and Viscosae has been pointed out as the reason for the genetic complexity of these groups of taxa. Based on this characterization a question emerges: could a very recent ongoing evolutionary process explain that morpho–environmental similarity? ISSR and cpSSR amplifications for 45 specimens belonging to taxa of Natrix and Viscosae subsections were developed, along their biogeographic distribution areas. Twenty-nine haplotypes were detected in the biogeographic area of both subsections, 79% were exclusive haplotypes, but the rest is shared between subsections Natrix and Viscosae species. Could that haplotype sharing be the result of potential hybridization between these taxa? Do current environmental conditions restrict the gene flow among taxa? The combination of ancestral genetic polymorphism, introgression, coalescence processes and periodic restricted environments (PRE) by glacial–interglacial environmental dynamics were discussed ...
- Published
- 2018
45. Personalized Cancer Models for Target Discovery and Precision Medicine
- Author
-
Christopher J. Kemp and Carla Grandori
- Subjects
0301 basic medicine ,Genetic complexity ,Cancer Research ,Computer science ,MEDLINE ,Genomics ,Computational biology ,Precision medicine ,Article ,03 medical and health sciences ,030104 developmental biology ,Oncology ,Drug development ,Neoplasms ,Genome profiling ,Animals ,Humans ,Snapshot (computer storage) ,Molecular Targeted Therapy ,Precision Medicine ,Human cancer - Abstract
Although cancer research is progressing at an exponential rate, translating this knowledge to develop better cancer drugs and more effectively match drugs to patients is lagging. Genome profiling of tumors provides a snapshot of the genetic complexity of individual tumors, yet this knowledge is insufficient to guide therapy for most patients. Model systems -usually cancer cell lines or mice – have been instrumental in cancer research and drug development, but translation of results to the clinic is inefficient, in part, because these models do not sufficiently reflect the complexity and heterogeneity of human cancer. Here, we discuss the potential of combining genomics with high throughput functional testing of patient derived tumor cells to overcome key roadblocks in both drug target discovery and precision medicine.
- Published
- 2018
46. The genetics of fruit flavour preferences
- Author
-
Denise M. Tieman and Harry J. Klee
- Subjects
Crops, Agricultural ,0106 biological sciences ,0301 basic medicine ,Genetic complexity ,Genetics ,Flavour ,food and beverages ,Biology ,Plants, Genetically Modified ,01 natural sciences ,Plant Breeding ,03 medical and health sciences ,030104 developmental biology ,Solanum lycopersicum ,Fruit ,Molecular Biology ,Genetics (clinical) ,010606 plant biology & botany - Abstract
Intensively bred fruit crops, including tomatoes and strawberries, are widely viewed as lacking flavour. The lack of breeder focus on the consumer is largely due to the genetic complexity of the flavour phenotype as well as a lack of a simple assay that can define consumer preferences. Rapid advances in genomics have opened up new opportunities to understand the chemistry and genetics of flavour. Here, we describe the underlying causes for the loss of flavour in fruits over time and delineate a blueprint for defining the chemistry of consumer liking, reducing that knowledge into a molecular roadmap for flavour improvement.
- Published
- 2018
47. When Monogenic Isn’t Monogenic—Unravelling the Oligogenic Architecture of the Developmental and Epileptic Encephalopathies
- Author
-
Ingrid E. Scheffer and Jianxiang Liao
- Subjects
0301 basic medicine ,Genetic complexity ,business.industry ,MEDLINE ,Computational biology ,Current Literature in Basic Science ,Clinical neurology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Medicine ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Comprehensive Analysis of Coding Variants Highlights Genetic Complexity in Developmental and Epileptic EncephalopathyTakata A, Nakashima M, Saitsu H, et al. Nat Commun. 2019;10(1):2506. doi:10.1038...
- Published
- 2019
48. Can molecular insights guide treatment of AML evolved from MPNs?
- Author
-
John D. Crispino and Raajit K. Rampal
- Subjects
Genetic complexity ,Myeloproliferative Disorders ,business.industry ,medicine.medical_treatment ,Clinical Biochemistry ,Hematopoietic Stem Cell Transplantation ,Bioinformatics ,medicine.disease ,Targeted therapy ,Leukemia, Myeloid, Acute ,Patient population ,Leukemia ,Oncology ,Risk Factors ,medicine ,Humans ,business - Abstract
Leukemic transformation of myeloproliferative neoplasms (MPNs) is associated with dismal outcomes. The genetic complexity of leukemic transformation of MPNs is being deciphered and will likely result in targeted therapy approaches. Ongoing trials are investigating the efficacy of emerging treatments for this high-risk patient population. This review has outlined recent progress in the understanding and treatment of leukemia arising from MPNs.
- Published
- 2021
49. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?
- Author
-
Arribas-Ayllon, Michael
- Subjects
ALZHEIMER'S disease diagnosis ,HUMAN chromosome abnormality diagnosis ,HUNTINGTON disease ,DATA analysis ,DISEASE susceptibility ,MEDICAL ethics - Abstract
Introduction or background Genetic testing for rare Mendelian disorders represents the dominant ethical paradigm in clinical and professional practice. Predictive testing for Huntington's disease is the model against which other kinds of genetic testing are evaluated, including testing for Alzheimer's disease. Sources of data This paper retraces the historical development of ethical reasoning in relation to predictive genetic testing and reviews a range of ethical, sociological and psychological literature from the 1970s to the present. Areas of agreement In the past, ethical reasoning has embodied a distinct style whereby normative principles are developed from a dominant disease exemplar. Areas of controversy This reductionist approach to formulating ethical frameworks breaks down in the case of disease susceptibility. Growing points Recent developments in the genetics of Alzheimer's disease present a significant case for reconsidering the ethics of disclosing risk for common complex diseases. Disclosing the results of susceptibility testing for Alzheimer's disease has different social, psychological and behavioural consequences. Furthermore, what genetic susceptibility means to individuals and their families is diffuse and often mitigated by other factors and concerns. Areas timely for developing research The ethics of disclosing a genetic diagnosis of susceptibility is contingent on whether professionals accept that probabilistic risk information is in fact ‘diagnostic’ and it will rely substantially on empirical evidence of how people actually perceive, recall and communicate complex risk information. [ABSTRACT FROM PUBLISHER]
- Published
- 2011
- Full Text
- View/download PDF
50. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
- Author
-
Hofmann, W. P., Fernandez, B., Herrmann, E., Welsch, C., Mihm, U., Kronenberger, B., Feldmann, G., Spengler, U., Zeuzem, S., and Sarrazin, C.
- Subjects
- *
MESSENGER RNA , *GENES , *HEPATITIS C virus , *LYMPHOPROLIFERATIVE disorders , *CRYOGLOBULINEMIA , *ONCOGENES - Abstract
Chronic hepatitis C virus (HCV) infection leads to mixed cryoglobulinaemia (MC) and B-cell non-Hodgkin lymphoma (B-NHL). Aberrant somatic hypermutation and deregulation of the oncogene BCL-6 is associated with lymphomagenesis. Recently, HCV was shown to induce BCL-6 mutations in vitro. The BCL-6 gene (area B) was cloned and sequenced from peripheral blood mononuclear cells (PBMC) of 21 chronically HCV-infected patients with or without MC and B-NHL, and six healthy controls. Mutational frequencies, genetic complexity and diversity were calculated. BCL-6 mRNA from PBMC was quantified by real-time polymerase chain reaction, and additional sustained virologic responders to antiviral therapy and HBV patients served as controls. The overall/recurrent mutational frequencies tended to be lower in MC and B-NHL patients when compared with controls ( P = 0.15 and 0.06, respectively). Genetic complexity was significantly lower in MC and B-NHL patients ( P = 0.025). BCL-6 mRNA concentration was decreased in all HCV patients when compared with healthy controls, sustained virologic responder and HBV patients ( P = 0.005). Although HCV can induce BCL-6 mutations in vitro, lower mutational frequencies and decreased BCL-6 mRNA expression in vivo suggest no major role of aberrant somatic hypermutation in HCV-associated MC and B-NHL. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.